We bring intelligence, experience, connections and smart financial investment to the table.
We invest in cutting-edge companies across Europe that are changing the world.
We are driven by the belief that innovation offers compelling answers to the most pressing problems facing the world – achieving sustainable prosperity.
Connect with ETF Partners.

We'd love to hear from you. Drop us an email, give us a call or follow us on LinkedIn, Medium or Twitter.
ETF Digest

Eagle Genomics takes latest funding past $25m and unveils new CEO and Chair


29 September 2023


We are thrilled to share that our portfolio company, Eagle Genomics, has appointed the distinguished former Microsoft executive, Dr. Victoria Kimonides, as their new CEO. πŸš€ πŸ‘©β€πŸ’Ό

Upon her appointment, Dr. Kimonides expressed her enthusiasm about Eagle Genomics’ potential to significantly impact large corporations by curating and analysing their extensive investments in microbiome research. She envisions aiding these companies in commercialising their research and creating sustainable solutions beneficial to both individuals and the environment. 🌏

In addition to this leadership change, Eagle Genomics has announced a successful fundraising round, securing over $4 million. This takes their total funding raised in the last year past the $25 million mark!

For more details, you can read the full article on Business Weekly newspaper HERE.